A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.

Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune ...

During a live event, Matthew Galsky, MD, discussed adjuvant nivolumab in muscle-invasive bladder cancer and the benefit in ...

New research suggests that an “often-overlooked” parasitic infection, already linked to bladder cancer, may also raise the risk of cervical cancer.

A supplemental biologics license application has been submitted to the FDA for nogapendekin alfa plus Bacillus ...

New bladder cancer treatment rolled out by NHS - Hundreds will benefit after the first targeted treatment for the most common ...

The team’s model predicted that approximately 103,000 cancers per year – around 5 percent of the 2 million new cancer ...

A new systematic review explores how prehabilitation—through exercise, education, nutrition, and lifestyle changes—affects ...

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking ...

CT scans performed in the US in 2023 alone could eventually lead to over 100,000 extra cancer cases, a new study claims.